These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 914742)

  • 1. Maple syrup urine disease. Thiamin responsive branched chain aminoaciduria: a unique case in an adult: (case report).
    Kannan V; Subramanyam K
    J Assoc Physicians India; 1977 Feb; 25(2):163-6. PubMed ID: 914742
    [No Abstract]   [Full Text] [Related]  

  • 2. So-called thiamin-responsive maple syrup urine disease: 15-year follow-up of the original patient.
    Scriver CR; Clow CL; George H
    J Pediatr; 1985 Nov; 107(5):763-5. PubMed ID: 4056978
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiamin-responsive maple syrup urine disease: seizures after 7 years of satisfactory metabolic control.
    Delis D; Michelakakis H; Katsarou E; Bartsocas CS
    J Inherit Metab Dis; 2001 Nov; 24(6):683-4. PubMed ID: 11768588
    [No Abstract]   [Full Text] [Related]  

  • 4. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiamin-responsive maple syrup urine disease in a patient antigenically missing dihydrolipoamide acyltransferase.
    Ellerine NP; Herring WJ; Elsas LJ; McKean MC; Klein PD; Danner DJ
    Biochem Med Metab Biol; 1993 Jun; 49(3):363-74. PubMed ID: 8347380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiamine non-responsive intermittent branched-chain ketoaciduria in a Laotian child.
    Pueschel SM
    J Inherit Metab Dis; 1986; 9(1):72. PubMed ID: 3088326
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of classical maple syrup urine disease "thiamine non-responsive".
    Wong PW; Justice P; Smith GF; Hsia DY
    Clin Genet; 1972; 3(1):27-33. PubMed ID: 5066975
    [No Abstract]   [Full Text] [Related]  

  • 8. [Latest data on chemical properties and the physiological role of thiamine and its phosphoric esters].
    Tettamanti G
    Minerva Dietol Gastroenterol; 1985; 31(2):75-94. PubMed ID: 3897910
    [No Abstract]   [Full Text] [Related]  

  • 9. Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings.
    Sener RN
    Comput Med Imaging Graph; 2007 Mar; 31(2):106-10. PubMed ID: 17207604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maple syrup urine disease. Description of a case (classical form) and clinico-therapeutic considerations].
    Fregonese B; La Medica G; Rainero L; Famularo L; Vallarino G; Merlini M
    Minerva Pediatr; 1973 Apr; 25(13):604-12. PubMed ID: 4708946
    [No Abstract]   [Full Text] [Related]  

  • 11. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
    Dennis JA; Healy PJ
    Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thiamine in a patient with a variant form of branched-chian ketoaciduria.
    Duran M; Tielens AG; Wadman SK; Stigter JC; Kleijer WJ
    Acta Paediatr Scand; 1978 May; 67(3):367-72. PubMed ID: 654914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin B1 dependency].
    Kuroda Y; Naito E
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):225-8. PubMed ID: 9645049
    [No Abstract]   [Full Text] [Related]  

  • 14. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34.
    Fisher CW; Lau KS; Fisher CR; Wynn RM; Cox RP; Chuang DT
    Biochem Biophys Res Commun; 1991 Jan; 174(2):804-9. PubMed ID: 1847055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maple syrup urine disease: case report of 2 Thai infants.
    Chiemchanya S; Suthutvoravut U; Visudhiphan P
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():116-20. PubMed ID: 2732631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exfoliative erythroderma resulting from inadequate intake of branched-chain amino acids in infants with maple syrup urine disease.
    Northrup H; Sigman ES; Hebert AA
    Arch Dermatol; 1993 Mar; 129(3):384-5. PubMed ID: 8447687
    [No Abstract]   [Full Text] [Related]  

  • 19. Late-onset branched-chain ketoaciduria: (maple syrup urine disease).
    Morris MD; Fisher DA; Fiser R
    J Lancet; 1966 Mar; 86(3):149-52. PubMed ID: 5904649
    [No Abstract]   [Full Text] [Related]  

  • 20. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.